167 related articles for article (PubMed ID: 25222742)
1. Scientists versus regulators: precaution, novelty & regulatory oversight as predictors of perceived risks of engineered nanomaterials.
Beaudrie CE; Satterfield T; Kandlikar M; Harthorn BH
PLoS One; 2014; 9(9):e106365. PubMed ID: 25222742
[TBL] [Abstract][Full Text] [Related]
2. Expert views on regulatory preparedness for managing the risks of nanotechnologies.
Beaudrie CE; Satterfield T; Kandlikar M; Harthorn BH
PLoS One; 2013; 8(11):e80250. PubMed ID: 24244662
[TBL] [Abstract][Full Text] [Related]
3. From cradle-to-grave at the nanoscale: gaps in U.S. regulatory oversight along the nanomaterial life cycle.
Beaudrie CE; Kandlikar M; Satterfield T
Environ Sci Technol; 2013 Jun; 47(11):5524-34. PubMed ID: 23668487
[TBL] [Abstract][Full Text] [Related]
4. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH
J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041
[TBL] [Abstract][Full Text] [Related]
5. Controlling the risks of nano-enabled products through the life cycle: The case of nano copper oxide paint for wood protection and nano-pigments used in the automotive industry.
Semenzin E; Subramanian V; Pizzol L; Zabeo A; Fransman W; Oksel C; Hristozov D; Marcomini A
Environ Int; 2019 Oct; 131():104901. PubMed ID: 31279910
[TBL] [Abstract][Full Text] [Related]
6. Is the risk from nanomaterials perceived as different from the risk of 'chemicals' by the Australian public?
Capon A; Rolfe M; Gillespie J; Smith W
Public Health Res Pract; 2016 Apr; 26(2):. PubMed ID: 27734061
[TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of nanomaterial definitions and safety evaluation considerations.
Boverhof DR; Bramante CM; Butala JH; Clancy SF; Lafranconi M; West J; Gordon SC
Regul Toxicol Pharmacol; 2015 Oct; 73(1):137-50. PubMed ID: 26111608
[TBL] [Abstract][Full Text] [Related]
8. Barriers to responsible innovation of nanotechnology applications in food and agriculture: A study of US experts and developers.
Cummings CL; Kuzma J; Kokotovich A; Glas D; Grieger K
NanoImpact; 2021 Jul; 23():100326. PubMed ID: 35559827
[TBL] [Abstract][Full Text] [Related]
9. ONE Nano: NIEHS's strategic initiative on the health and safety effects of engineered nanomaterials.
Schug TT; Johnson AF; Balshaw DM; Garantziotis S; Walker NJ; Weis C; Nadadur SS; Birnbaum LS
Environ Health Perspect; 2013 Apr; 121(4):410-4. PubMed ID: 23407114
[TBL] [Abstract][Full Text] [Related]
10. Perceptions of risk from nanotechnologies and trust in stakeholders: a cross sectional study of public, academic, government and business attitudes.
Capon A; Gillespie J; Rolfe M; Smith W
BMC Public Health; 2015 Apr; 15():424. PubMed ID: 25928741
[TBL] [Abstract][Full Text] [Related]
11. Nanomaterials for environmental remediation: investigating the role of nanoinformatics in support of environmental, health, and safety oversight of nanotechnologies at the local level.
Massawe E
J Environ Health; 2013; 76(1):8-17. PubMed ID: 23947284
[TBL] [Abstract][Full Text] [Related]
12. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
13. Review of Research Trends and Methods in Nano Environmental, Health, and Safety Risk Analysis.
Erbis S; Ok Z; Isaacs JA; Benneyan JC; Kamarthi S
Risk Anal; 2016 Aug; 36(8):1644-65. PubMed ID: 26882074
[TBL] [Abstract][Full Text] [Related]
14. Considerations on the EU definition of a nanomaterial: science to support policy making.
Bleeker EA; de Jong WH; Geertsma RE; Groenewold M; Heugens EH; Koers-Jacquemijns M; van de Meent D; Popma JR; Rietveld AG; Wijnhoven SW; Cassee FR; Oomen AG
Regul Toxicol Pharmacol; 2013 Feb; 65(1):119-25. PubMed ID: 23200793
[TBL] [Abstract][Full Text] [Related]
15. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
16. Environmental risk assessment of engineered nano-SiO
Wang Y; Nowack B
Environ Toxicol Chem; 2018 May; 37(5):1387-1395. PubMed ID: 29315795
[TBL] [Abstract][Full Text] [Related]
17. Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.
Stone V; Johnston HJ; Balharry D; Gernand JM; Gulumian M
Risk Anal; 2016 Aug; 36(8):1538-50. PubMed ID: 27285586
[TBL] [Abstract][Full Text] [Related]
18. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
Fairbrother A; Fairbrother JR
Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
[TBL] [Abstract][Full Text] [Related]
19. Politics and scientific expertise: scientists, risk perception, and nuclear waste policy.
Barke RP; Jenkins-Smith HC
Risk Anal; 1993 Aug; 13(4):425-39. PubMed ID: 8234951
[TBL] [Abstract][Full Text] [Related]
20. The Life Cycle of Engineered Nanoparticles.
González-Gálvez D; Janer G; Vilar G; Vílchez A; Vázquez-Campos S
Adv Exp Med Biol; 2017; 947():41-69. PubMed ID: 28168665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
